<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05009628</url>
  </required_header>
  <id_info>
    <org_study_id>2019_0006</org_study_id>
    <nct_id>NCT05009628</nct_id>
  </id_info>
  <brief_title>Is Routine Postoperative Oxygen Therapy Still Necessary in 2020?</brief_title>
  <acronym>FreeO2</acronym>
  <official_title>Is Routine Postoperative Oxygen Therapy Still Necessary in 2020?</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hopital Foch</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hopital Foch</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study by automated control of oxygen supply in the immediate&#xD;
      postoperative period is to show the possibility of immediate weaning in the postoperative&#xD;
      period in case of remifentanil use and complete reversion of curarization.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The main hypothesis of this study is that classical oxygen therapy at 3l/min is futile in the&#xD;
      postoperative period of a so-called modern anaesthesia and that a total weaning within one&#xD;
      hour after arrival in the ICU is possible whatever the postoperative position of the patient.&#xD;
      The aim is therefore to include patients who have to undergo a scheduled surgery under&#xD;
      anaesthetic sedation (analgesia with remifentanil) or general anaesthesia (combining&#xD;
      remifentanil, propofol rocuronium) for ambulatory surgery. The trial is interventional,&#xD;
      randomized, monocentric to demonstrate the absence of interest of prolonged postoperative&#xD;
      oxygen therapy under specific intraoperative conditions.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 5, 2021</start_date>
  <completion_date type="Anticipated">August 5, 2022</completion_date>
  <primary_completion_date type="Anticipated">July 5, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>interventional study with 4 paralel arms ; randomization is realised according to a centralized and balanced 2x2 factorial design</intervention_model_description>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Oxygen withdrawal time</measure>
    <time_frame>1 day</time_frame>
    <description>Time (min) to achieve zero O2 flow for at least 15 consecutive minutes</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Amount of O2 needed to reach the target saturation value (SpO2)</measure>
    <time_frame>1 day</time_frame>
    <description>Number of liters of O2 needed postoperatively</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of patients weaned within the first hour</measure>
    <time_frame>1 day</time_frame>
    <description>Zero O2 flow for at least 15 consecutive minutes</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Signature time in the ICU</measure>
    <time_frame>1 day</time_frame>
    <description>Minutes since admission</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Maximum flow rate during the evaluation period</measure>
    <time_frame>1 day</time_frame>
    <description>Maximum value of O2 flow in liter/min</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The patient's comfort</measure>
    <time_frame>1 day</time_frame>
    <description>Numerical scale between 0 and 10 to evaluate patient comfort</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Complications during hospital stay</measure>
    <time_frame>30 days</time_frame>
    <description>Length of hospital stay</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Complications during stay in intensive care unit</measure>
    <time_frame>30 days</time_frame>
    <description>Length of stay in intensive care unit</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mortality during stay in hospital</measure>
    <time_frame>30 days</time_frame>
    <description>Hospital mortality</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Complications after stay in hospital</measure>
    <time_frame>30 days</time_frame>
    <description>Rehospitalization</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Postoperative Oxygen Therapy</condition>
  <arm_group>
    <arm_group_label>automated oxygenation with a sitting patient position in the ICU</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>controlled oxygenation with a lying patient position in the ICU</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>automated oxygenation with the patient lying down in the ICU</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>control oxygenation with the patient in a sitting position in the ICU</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>automated oxygenation with a sitting patient position in the ICU</intervention_name>
    <description>Oxygenation will be done with the Free O2 device via oxygen goggles or a face mask and with an O2 prescription to obtain a SpO2&gt; 94%. The patient's position in the ICU will be a sitting position with the chest raised at an angle greater than 45°.</description>
    <arm_group_label>automated oxygenation with a sitting patient position in the ICU</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Automated oxygenation with the patient lying down in the ICU</intervention_name>
    <description>Oxygenation will be done with the Free O2 device via oxygen goggles or a face mask and with an O2 prescription to obtain a SpO2&gt; 94%. The patient's position in the ICU will be a recumbent position with the head elevated to a maximum of 10</description>
    <arm_group_label>automated oxygenation with the patient lying down in the ICU</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Oxygenation is controlled with the patient in a sitting position in the ICU.</intervention_name>
    <description>ICU. Oxygenation will be done via the same interface in manual mode where the post-interventional monitoring room nurse modifies the flow to maintain oxygen saturation above 94%. The patient's position in the ICU will be a sitting position with the chest raised at an angle greater than 45°.</description>
    <arm_group_label>control oxygenation with the patient in a sitting position in the ICU</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients managed by the Anesthesia Department of the Foch Hospital;&#xD;
&#xD;
          -  Anesthetic sedation (analgesia with remifentanil) or general anesthesia (combining&#xD;
             remifentanil, propofol and possibly rocuronium);&#xD;
&#xD;
          -  Men or women over 18 and under 80 years of age;&#xD;
&#xD;
          -  To benefit from a surgical intervention scheduled &gt; 48 hours in relation to the&#xD;
             procedure;&#xD;
&#xD;
          -  Scheduled outpatient surgery;&#xD;
&#xD;
          -  Have signed a consent form;&#xD;
&#xD;
          -  Be affiliated to a health insurance plan.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Pregnant or nursing patients;&#xD;
&#xD;
          -  Oxygen dependent preoperatively or at risk of oxygen dependence postoperatively;&#xD;
&#xD;
          -  Lung resection surgery;&#xD;
&#xD;
          -  Brain surgery (intracerebral neurosurgery); ENT surgery requiring a half-seated&#xD;
             position after the operation;&#xD;
&#xD;
          -  Being deprived of liberty or under guardianship.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Morgan LE GUEN, PhD</last_name>
    <phone>01 46 25 29 98</phone>
    <email>m.leguen@hopital-foch.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Elisabeth Hulier-Ammar</last_name>
    <phone>0146251175</phone>
    <email>drci-promotion@hopital-foch.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Hôpital Foch</name>
      <address>
        <city>Suresnes</city>
        <zip>92150</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Morgan LE GUEN, PhD</last_name>
      <phone>0146252998</phone>
      <email>m.leguen@hopital-foch.com</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>August 6, 2021</study_first_submitted>
  <study_first_submitted_qc>August 11, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">August 17, 2021</study_first_posted>
  <last_update_submitted>August 11, 2021</last_update_submitted>
  <last_update_submitted_qc>August 11, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 17, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

